FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for Synthroid (levothyroxine sodium) filed by AbbVie, indicating an approved change to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Goiter
• Hypothyroidism

Drugs mentioned

• SYNTHROID (LEVOTHYROXINE SODIUM)

Snippet

SUPPL AP for SYNTHROID (LEVOTHYROXINE SODIUM)